Adjuvant Systemic Therapy For Intermediate And Large Gastric Gastrointestinal Stromal Tumors (GISTs): Is There A Survival Benefit Following Margin Negative Surgical Resection?

The value of adjuvant systemic therapy after margin-negative resection for gastric gastrointestinal stromal tumors (GISTs) remains unclear.

Source: American Journal of Surgery - October 10, 2019 Category: Surgery Authors: Dhruv J. Patel, Waseem Lutfi, Patrick Sweigert, Emanuel Eguia, Gerard Abood, Lawrence Knab, Paul C. Kuo, Marshall S. Baker Source Type: research